Extremozyme's Grant

Extremozyme raised a round of funding on July 20, 2006. Investors include National Science Foundation.

Extremozyme is a company that received a STTR Phase I grant for a project entitled: DNA Assembly for Directed Expression of Industrial Enzymes Using a Novel Hyperthermophilic Genome. Their project aim…

Articles about Extremozyme's Grant: